Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001293301-11-000017
Filing Date
2011-08-25
Accepted
2011-08-25 16:56:41
Documents
1
Period of Report
2011-08-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2221
  Complete submission text file 0001293301-11-000017.txt   3562
Mailing Address 909 THIRD AVENUE NEW YORK NY 10022
Business Address 909 THIRD AVENUE NEW YORK NY 10022 (212)421-7850
FOREST LABORATORIES INC (Issuer) CIK: 0000038074 (see all company filings)

EIN.: 111798614 | State of Incorp.: DE | Fiscal Year End: 1202
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALLIANCE CAPITAL 1345 AVENUE OF THE AMERICAS NEW YORK NY 10105
Business Address
LIEBERMAN GERALD M (Reporting) CIK: 0001234346 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-05438 | Film No.: 111057076